What is Oxymorphone?

Oxymorphone is a semi-synthetic opioid derived from thebaine, used primarily for managing moderate to severe pain. It works by altering the way the brain and nervous system respond to pain, providing relief for patients dealing with chronic or post-surgical pain. Available in immediate and extended-release formulations, it is prescribed under brand names such as Opana.

Because of its high potency, oxymorphone carries a significant risk of abuse, addiction, and overdose. It is classified as a Schedule II controlled substance in the United States, indicating a high potential for misuse that can lead to severe psychological or physical dependence.

In the context of substance abuse and mental health, oxymorphone is a frequent contributor to opioid use disorder (OUD). Its misuse—whether by taking higher doses, using without a prescription, or altering its form for injection or snorting—can lead to serious health consequences. Treatment for oxymorphone addiction often involves medication-assisted therapies such as buprenorphine or naltrexone, alongside counseling and behavioral interventions.

Legally, due to the opioid epidemic, oxymorphone has come under increased scrutiny, with some formulations being removed from the market. Health professionals are advised to monitor its use closely and educate patients on the risks associated with opioid medications.